• Therapeutic Areas/ 
  • Respiratory diseases

Respiratory diseases

The severity of respiratory tract diseases is constantly increasing (allergies, environmentally conditioned asthma, smoking, etc.). The development and marketing activities of the Chiesi Group are focused on products that are specifically designed for the treatment of respiratory tract diseases. Most important in this area is the patenting of inhalation sprays based on freon-free Modulite technology.

Ingredients:
  • Beclometasone + formoterol
  • Beclometasone dipropionate
  • Beclometasone dipropionate
  • Formoterol fumarate
  • Montelukast

Product informations are intended for health care professionals. For complete prescribing informations please refer to the summary of Product Characteristics on http://www.anm.ro/anm/anm_list.asp or consult your pharmacist or doctor for further details regarding our products.